Skip to content
Master Plan Tariffs Tool
🇧🇾

Pharmaceutical Products from Belarus Tariff: 10% (2026)

Tariff Rate Breakdown

10%
Section 122 Base
10%
Effective Rate

Pharmaceutical Products from Belarus represent an important segment of bilateral trade, with approximately $0.5B in total bilateral trade.

As of mid-2026, pharmaceutical products imports from Belarus face a base tariff rate of 10% under the Section 301 forced-labor tariff (a two-tier 10%/12.5% duty), which replaced the flat 10% Section 122 rate when it expired July 24, 2026. Section 122 had itself replaced the IEEPA reciprocal tariff following the Supreme Court's 6-3 ruling in Learning Resources v. Trump (with V.O.S. Selections) on February 20, 2026.

Under the Trade Act of 1974, Section 122 tariffs are limited to 150 days, so the flat 10% Section 122 rate expired on July 24, 2026. It was replaced the same day by USTR's Section 301 forced-labor tariff, and Belarus's current 10% base surcharge is that two-tier (10%/12.5%) rate.

Pharmaceutical Products (HTS Chapter 30) generally enter duty-free at the MFN level, with the base forced-labor tariff as the primary duty. No additional Section 232 or Section 301 surcharges apply to most products in this category from Belarus.

Key products in HTS Chapter 30 imported from Belarus include Vaccines, Antibiotics, Insulin, Bandages, Diagnostic reagents, and Blood products.

Common Products in Chapter 30

VaccinesAntibioticsInsulinBandagesDiagnostic reagentsBlood productsPharmaceutical dosage formsFirst-aid kits

Calculate Your Import Duty

Use our tariff calculator to estimate the exact duty on your pharmaceutical products imports from Belarus.

Open Tariff Calculator

Frequently Asked Questions

What is the current tariff rate on pharmaceutical products from Belarus?
As of mid-2026, pharmaceutical products from Belarus face a base tariff of 10% under the Section 301 forced-labor tariff, which replaced the flat 10% Section 122 rate on July 24, 2026. The effective rate is about 10% on the most-affected products.
Will the tariff on pharmaceutical products from Belarus change?
The flat 10% Section 122 tariff expired July 24, 2026 and was replaced the same day by the Section 301 forced-labor tariff; Belarus's current 10% base surcharge is that two-tier (10%/12.5%) rate, covering roughly 60 economies. In August 2026, 25 states sued to block the forced-labor tariff, but CBP continues collecting it while the case proceeds.
How did the Supreme Court ruling affect pharmaceutical products imports from Belarus?
The Supreme Court's February 20, 2026 ruling struck down IEEPA reciprocal tariffs as exceeding presidential authority. The president signed a replacement flat 10% tariff under Section 122 the same day, effective February 24; that rate expired July 24, 2026 and was replaced by the Section 301 forced-labor tariff (now 10% for Belarus).

Advertisement

Tariff rates change fast. Stay ahead.

Free alerts when US import tariff rates change. Join importers and trade professionals who stay informed.

No spam. Unsubscribe anytime.

15% of CAPE claims rejected. Is yours at risk?

Get Pre-Filing Audit →